Healthcare stocks with strong revenue growth and attractive valuations
at seekingalpha.com (Tue, 27-Oct 7:10 AM)
CorMedix Delivers Record Q2 Revenue and Raises 2026 EBITDA Outlook After DefenCath Expansion
Market Chameleon (Thu, 13-Aug 10:37 AM)
CorMedix Posts Robust Q2 Revenue, Ups EBITDA Guidance—DefenCath Drives Growth and Margin Expansion
Market Chameleon (Thu, 13-Aug 8:15 AM)
